Deutsch-Wagram, Austria

Renate Kunert



 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2009-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Renate Kunert: A Pioneer in Cancer Research

Introduction

Renate Kunert, an accomplished inventor hailing from Deutsch-Wagram, Austria, has made significant contributions to the field of cancer research through her groundbreaking inventions. With a total of four patents to her name, her work focuses on innovations related to monoclonal antibodies that have the potential to revolutionize therapeutic treatments for cancer.

Latest Patents

Renate's latest patents include a recombinant human IgM antibody effective against cancer cells. This innovative product is a recombinant human monoclonal pentameric IgM antibody that possesses the ability for oligospecific binding to purified ganglioside epitopes GD3, GM3, GD2, and GM1. The antibody specifically targets malignant cancer cells, including melanoma cells, small cell lung cancer cells, glioblastoma cells, and estrogen receptor-negative metastatic breast cancer cells. Furthermore, the patent describes a cell line that produces this IgM antibody, detailing its potential use as both a diagnostic tool and a therapeutic agent.

Career Highlights

Throughout her career, Renate has worked with notable institutions such as Katinger GmbH and Polymun Scientific Immunobiological Research GmbH. Her experience in these organizations has allowed her to refine her research and develop her innovative ideas into practical applications.

Collaborations

Renate has collaborated with several esteemed professionals in her field, including Hermann W. Katinger and Gabriela Stiegler. Working alongside such accomplished colleagues has enhanced her ability to drive forward innovative projects in cancer therapy and diagnostics.

Conclusion

Renate Kunert's contributions to cancer research through her inventive work on recombinant human IgM antibodies reflect her dedication and ingenuity. Her impressive portfolio of patents demonstrates her impact on the medical community and highlights her role as a pioneering inventor in the fight against cancer. As innovations continue to evolve, Renate's work will undoubtedly play a vital role in advancing therapeutic options for patients around the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…